drugset / Trial / NCT02062658
Extending Ketamine's Effects in OCD With Exposure and Response Prevention (EX/RP)
Phase 2
Completed
10 enrolled
New York State Psychiatric Institute
National Institute of Mental Health (NIMH) · collab
NaSingle-groupOpen-labelTreatment
Summary
This study investigates if a single dose of IV Ketamine can rapidly improve Obsessive-Compulsive Disorder (OCD) symptoms and whether these effect can be maintained with a condensed course of a type of Cognitive Behavioral Therapy called Exposure and Response Prevention (EX/RP). You will be compensated for your time and travel. Participants must be between the ages of 18-55.
Timeline
- Start
- 2013-12
- Primary completion
- 2015-12
- Completion
- 2015-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ketamine | Small molecule | 0.5 mg/kg | Intravenous |